These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 19033265)

  • 1. Metoprolol succinate combination in the treatment of hypertension.
    Papadopoulos DP; Papademetriou V
    Angiology; 2009; 60(5):608-13. PubMed ID: 19033265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT).
    Frishman WH; Hainer JW; Sugg J;
    Am J Hypertens; 2006 Apr; 19(4):388-95. PubMed ID: 16580575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combination.
    Papademetriou V; Hainer JW; Sugg J; Munzer D;
    Am J Hypertens; 2006 Dec; 19(12):1217-25. PubMed ID: 17161766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metoprolol CR/XL: advanced formulation of a classical beta-blocker].
    Kobalava ZhD; Gudkov KM
    Kardiologiia; 2003; 43(9):91-100. PubMed ID: 14593374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metoprolol succinate extended release/hydrochlorothiazide combination tablets.
    Hainer JW; Sugg J
    Vasc Health Risk Manag; 2007; 3(3):279-88. PubMed ID: 17703635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW
    Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving the therapeutic balance between efficacy and tolerability in antihypertensive drugs--the rationale and benefits of combining felodipine and metoprolol.
    Trenkwalder P; Elmfeldt D
    J Hum Hypertens; 1995 Jul; 9 Suppl 2():S37-42. PubMed ID: 7562898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and pharmacokinetics of Logimax, a new extended-release combination tablet of felodipine and metoprolol.
    Abrahamsson B; Edgar B; Lidman K; Wingstrand K
    Blood Press Suppl; 1993; 1():10-5. PubMed ID: 8173686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of beta-blockers on sleep in patients with mild hypertension: a randomized trial between nebivolol and metoprolol.
    Yilmaz MB; Erdem A; Yalta K; Turgut OO; Yilmaz A; Tandogan I
    Adv Ther; 2008 Sep; 25(9):871-83. PubMed ID: 18758699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Atenolol or metoprolol as beta-blocker in the treatment of hypertension].
    van den Born BJ; Brewster LM; Koopmans RP; van Montfrans GA
    Ned Tijdschr Geneeskd; 2005 Aug; 149(32):1808-9. PubMed ID: 16121668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tablet splitting: Product quality assessment of metoprolol succinate extended release tablets.
    Zhao N; Zidan A; Tawakkul M; Sayeed VA; Khan M
    Int J Pharm; 2010 Nov; 401(1-2):25-31. PubMed ID: 20849940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antihypertensive first-line and add-on treatment with a fixed controlled release combination of metoprololsuccinate/hydrochlorothiazide. Prospective doctor's office observational study in 14,964 patients].
    Hildemann SK; Fischer HM; Bohlscheid V; Pittrow D
    MMW Fortschr Med; 2003 Apr; 145(14):42. PubMed ID: 15072279
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of metoprolol CR/ZOK in the cardiological practice].
    Podzolkov VI; Samoĭlenko VV; Osadchiĭ KK; Strizhakov LA
    Ter Arkh; 2000; 72(9):78-80. PubMed ID: 11076427
    [No Abstract]   [Full Text] [Related]  

  • 14. Pulsatile multiparticulate drug delivery system for metoprolol succinate.
    Jagdale SC; Chede SM; Gulwady R; Kuchekar BS; Lokhande PD; Shah TP; Chabukswar AR
    Arch Pharm Res; 2011 Mar; 34(3):369-76. PubMed ID: 21547667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discordant beta-blocker effects on clinic, ambulatory, resting, and exercise hemodynamics in patients with hypertension.
    Beitelshees AL; Zineh I; Yarandi HN; Pauly DF; Johnson JA
    Pharmacotherapy; 2006 Sep; 26(9):1247-54. PubMed ID: 16945046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic implications of extended-release metoprolol succinate for heart failure in the MERIT-HF trial: a US perspective of the MERIT-HF trial.
    Caro JJ; Migliaccio-Walle K; O'Brien JA; Nova W; Kim J; Hauch O; Hillson E; Wedel H; Hjalmarson A; Gottlieb S; Deedwania PC; Wikstrand J;
    J Card Fail; 2005 Dec; 11(9):647-56. PubMed ID: 16360958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo pharmacodynamic properties of metoprolol in fructose-fed hypertensive rats.
    Di Verniero CA; Silberman EA; Mayer MA; Opezzo JA; Taira CA; Höcht C
    J Cardiovasc Pharmacol; 2008 Jun; 51(6):532-41. PubMed ID: 18475202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prospects of use of the combined preparation logimax in patients with essential hypertension].
    Ol'binskaia LI; Khapaev BA; Zheleznykh EA
    Ter Arkh; 2002; 74(1):61-3. PubMed ID: 11878064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. beta1-Adrenergic receptor polymorphisms influence the response to metoprolol monotherapy in patients with essential hypertension.
    Liu J; Liu ZQ; Yu BN; Xu FH; Mo W; Zhou G; Liu YZ; Li Q; Zhou HH
    Clin Pharmacol Ther; 2006 Jul; 80(1):23-32. PubMed ID: 16815314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aiming for steady 24-hour plasma concentrations: a comparison of two calcium antagonist and beta-blocker combinations.
    Eriksson M; Nyberg G; Lidman K; Olofsson B; Bergstrand R
    Blood Press Suppl; 1993; 1():16-21. PubMed ID: 7909705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.